LOADING
Comparing Merck & Company (MRK) and Coinbase Global (COIN) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | COIN |
|---|---|---|
| Price | $144.30 | $183.00 |
| Change Today | +0.34% | -3.32% |
| Market Cap | $356.0B | $48.3B |
| P/E Ratio | 114.5 | -- |
| Forward P/E | 15.3 | 54.4 |
| PEG Ratio | 2.71 | 2.37 |
| EPS | $1.26 | $-3.86 |
| Revenue Growth (YoY) | 5.1% | -17.3% |
| Profit Margin | 4.8% | -16.3% |
| Return on Equity | 7.0% | -7.8% |
| Dividend Yield | 2.31% | -- |
| Beta | 0.23 | 3.39 |
| 52-Week High | $156.00 | $402.16 |
| 52-Week Low | $79.67 | $139.11 |
| Volume | 9.7M | 12.9M |
Merck & Company is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.